{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:09:31Z","timestamp":1790003371476,"version":"4.0.1"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06218-8","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:58:09Z","timestamp":1790002689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phytogenic Nanoparticles for Parkinson\u2019s Disease Therapy: Mechanistic Insights, Brain-Targeted Delivery and Neuroprotective Potential"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4487-1532","authenticated-orcid":false,"given":"Deepika","family":"Khatiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8832-3814","authenticated-orcid":false,"given":"Swapnaneel","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4341-5524","authenticated-orcid":false,"given":"Manjyoti","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0375-2835","authenticated-orcid":false,"given":"Shourav","family":"Sangroula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0440-6983","authenticated-orcid":false,"given":"Bhargab Jyoti","family":"Sahariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-9997","authenticated-orcid":false,"given":"Manoj Kumar","family":"Deka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5905-0903","authenticated-orcid":false,"given":"Amit Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"6218_CR1","doi-asserted-by":"publisher","first-page":"1535682","DOI":"10.3389\/FMED.2025.1535682\/FULL","volume":"12","author":"VK Yadav","year":"2025","unstructured":"Yadav VK, Dhanasekaran S, Choudhary N et al (2025) Recent advances in nanotechnology for Parkinson\u2019s disease: diagnosis, treatment, and future perspectives. Front Med (Lausanne) 12:1535682. https:\/\/doi.org\/10.3389\/FMED.2025.1535682\/FULL","journal-title":"Front Med (Lausanne)"},{"key":"6218_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/JNNP-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91:795\u2013808. https:\/\/doi.org\/10.1136\/JNNP-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6218_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/JAMA.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548\u2013560. https:\/\/doi.org\/10.1001\/JAMA.2019.22360","journal-title":"JAMA"},{"key":"6218_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/S40035-023-00392-8","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang B, Guo J (2023) Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Transl Neurodegener 12:59. https:\/\/doi.org\/10.1186\/S40035-023-00392-8","journal-title":"Transl Neurodegener"},{"key":"6218_CR5","doi-asserted-by":"publisher","unstructured":"Elangovan A, Dahiya B, Kirola L, et al (2024) Does gut brain axis has an impact on Parkinson\u2019s disease (PD)? Ageing Res Rev 94:. https:\/\/doi.org\/10.1016\/j.arr.2023.102171","DOI":"10.1016\/j.arr.2023.102171"},{"key":"6218_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/MDS.28526;PAGEGROUP:STRING:PUBLICATION","volume":"36","author":"P Borghammer","year":"2021","unstructured":"Borghammer P, Horsager J (2021) The logic and pitfalls of Parkinson\u2019s as brain- versus body-first subtypes. Mov Disord 36:785\u2013786. https:\/\/doi.org\/10.1002\/MDS.28526;PAGEGROUP:STRING:PUBLICATION","journal-title":"Mov Disord"},{"key":"6218_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105557","author":"P Borghammer","year":"2021","unstructured":"Borghammer P, Horsager J, Andersen K et al (2021) Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2021.105557","journal-title":"Neurobiol Dis"},{"key":"6218_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/J.NEUROL.2023.11.004","volume":"180","author":"B Bonaz","year":"2024","unstructured":"Bonaz B (2024) The gut-brain axis in Parkinson\u2019s disease. Rev Neurol (Paris) 180:65\u201378. https:\/\/doi.org\/10.1016\/J.NEUROL.2023.11.004","journal-title":"Rev Neurol (Paris)"},{"key":"6218_CR9","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.4103\/NRR.NRR-D-24-00994","volume":"20","author":"SJ Park","year":"2024","unstructured":"Park SJ, Kim KW, Lee EJ (2024) Gut\u2013brain axis and environmental factors in Parkinson\u2019s disease: bidirectional link between disease onset and progression. Neural Regen Res 20:3416. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00994","journal-title":"Neural Regen Res"},{"key":"6218_CR10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/MDC3.70029","volume":"12","author":"E Menozzi","year":"2025","unstructured":"Menozzi E, Schapira AHV, Borghammer P (2025) The gut-brain axis in Parkinson disease: emerging concepts and therapeutic implications. Mov Disord Clin Pract 12:904\u2013916. https:\/\/doi.org\/10.1002\/MDC3.70029","journal-title":"Mov Disord Clin Pract"},{"key":"6218_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13081202","author":"S Thangaleela","year":"2023","unstructured":"Thangaleela S, Sivamaruthi BS, Kesika P et al (2023) Neurological insights into sleep disorders in Parkinson\u2019s disease. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci13081202","journal-title":"Brain Sci"},{"key":"6218_CR12","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"key":"6218_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JPD-212976","volume":"12","author":"YY Tan","year":"2022","unstructured":"Tan YY, Jenner P, Chen SD (2022) Monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: past, present, and future. J Parkinsons Dis 12:477. https:\/\/doi.org\/10.3233\/JPD-212976","journal-title":"J Parkinsons Dis"},{"key":"6218_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7861\/CLINMED.2020-0220","volume":"20","author":"C Kobylecki","year":"2020","unstructured":"Kobylecki C (2020) Update on the diagnosis and management of Parkinson\u2019s disease. Clin Med 20:393. https:\/\/doi.org\/10.7861\/CLINMED.2020-0220","journal-title":"Clin Med"},{"key":"6218_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.32604\/BIOCELL.2024.049130","volume":"48","author":"T Liu","year":"2024","unstructured":"Liu T, Hao Y, Zhao L (2024) Pathogenic genes associated with Parkinson\u2019s disease: molecular mechanism overview. Biocell 48:707. https:\/\/doi.org\/10.32604\/BIOCELL.2024.049130","journal-title":"Biocell"},{"key":"6218_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/S13346-025-01799-8","volume":"16","author":"I Ali","year":"2026","unstructured":"Ali I, Adil M, Imran M et al (2026) Nanotechnology in Parkinson\u2019s disease: overcoming drug delivery challenges and enhancing therapeutic outcomes. Drug Deliv Transl Res 16:855\u2013893. https:\/\/doi.org\/10.1007\/S13346-025-01799-8","journal-title":"Drug Deliv Transl Res"},{"key":"6218_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES28227588","volume":"28","author":"N Kumari","year":"2023","unstructured":"Kumari N, Anand S, Shah K et al (2023) Emerging role of plant-based bioactive compounds as therapeutics in Parkinson\u2019s disease. Molecules 28:7588. https:\/\/doi.org\/10.3390\/MOLECULES28227588","journal-title":"Molecules"},{"key":"6218_CR18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54671","author":"T Grancharova","year":"2024","unstructured":"Grancharova T, Simeonova S, Pilicheva B, Zagorchev P (2024) Gold nanoparticles in Parkinson\u2019s disease therapy: a focus on plant-based green synthesis. Cureus. https:\/\/doi.org\/10.7759\/cureus.54671","journal-title":"Cureus"},{"key":"6218_CR19","doi-asserted-by":"publisher","unstructured":"Wen P, Sun Z, Gou F, et al (2025) Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders. Ageing Res Rev 104:. https:\/\/doi.org\/10.1016\/j.arr.2025.102667","DOI":"10.1016\/j.arr.2025.102667"},{"key":"6218_CR20","doi-asserted-by":"publisher","first-page":"42045","DOI":"10.1021\/ACSOMEGA.3C04862","volume":"8","author":"J Burns","year":"2023","unstructured":"Burns J, Buck AC, D\u2019 Souza S et al (2023) Nanophytomedicines as therapeutic agents for Parkinson\u2019s disease. ACS Omega 8:42045\u201342061. https:\/\/doi.org\/10.1021\/ACSOMEGA.3C04862","journal-title":"ACS Omega"},{"key":"6218_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/S11011-026-01868-Y","author":"S Saraswathi","year":"2026","unstructured":"Saraswathi S, Venkataravanappa JT, Nambiar C et al (2026) Plant-derived neuroprotective compounds and nanoformulations targeting Parkinson\u2019s disease: a semi-systematic review of mechanisms and therapeutic potential. Metab Brain Dis. https:\/\/doi.org\/10.1007\/S11011-026-01868-Y","journal-title":"Metab Brain Dis"},{"key":"6218_CR22","doi-asserted-by":"publisher","unstructured":"Naim A, Farooqui AM, Badruddeen, et al (2026) Nanoengineered phytochemicals overcome blood\u2013brain barrier constraints in neurodegenerative disorders. Front Neurol 17:1792829. https:\/\/doi.org\/10.3389\/FNEUR.2026.1792829\/FULL","DOI":"10.3389\/FNEUR.2026.1792829\/FULL"},{"key":"6218_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/1389200221666201124123405","volume":"22","author":"S Sharma","year":"2021","unstructured":"Sharma S, Rabbani SA, Agarwal T et al (2021) Nanotechnology driven approaches for the management of Parkinson\u2019s disease: current status and future perspectives. Curr Drug Metab 22:287\u2013298. https:\/\/doi.org\/10.2174\/1389200221666201124123405","journal-title":"Curr Drug Metab"},{"key":"6218_CR24","doi-asserted-by":"publisher","first-page":"1453499","DOI":"10.3389\/FNINS.2024.1453499\/FULL","volume":"18","author":"R Izadi","year":"2024","unstructured":"Izadi R, Bahramikia S, Akbari V (2024) Green synthesis of nanoparticles using medicinal plants as an eco-friendly and therapeutic potential approach for neurodegenerative diseases: a comprehensive review. Front Neurosci 18:1453499. https:\/\/doi.org\/10.3389\/FNINS.2024.1453499\/FULL","journal-title":"Front Neurosci"},{"key":"6218_CR25","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.2147\/IJN.S419369","volume":"18","author":"H Singh","year":"2023","unstructured":"Singh H, Desimone MF, Pandya S et al (2023) Revisiting the green synthesis of nanoparticles: uncovering influences of plant extracts as reducing agents for enhanced synthesis efficiency and its biomedical applications. Int J Nanomedicine 18:4727\u20134750. https:\/\/doi.org\/10.2147\/IJN.S419369","journal-title":"Int J Nanomedicine"},{"key":"6218_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCOWO.2024.100014","volume":"3","author":"SM Abegunde","year":"2024","unstructured":"Abegunde SM, Afolayan BO, Ilesanmi TM (2024) Ensuring sustainable plant-assisted nanoparticles synthesis through process standardization and reproducibility: challenges and future directions \u2013 a review. Sustain Chem One World 3:100014. https:\/\/doi.org\/10.1016\/J.SCOWO.2024.100014","journal-title":"Sustain Chem One World"},{"issue":"1","key":"6218_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/BMRI\/9207147","volume":"2026","author":"MH Mobarak","year":"2026","unstructured":"Mobarak MH, Al Mahmud MZ, Hossain A et al (2026) Advances of green\u2010synthesized nanoparticles for biomedical applications. BioMed Res Int 9207147. https:\/\/doi.org\/10.1155\/BMRI\/9207147","journal-title":"BioMed Res Int"},{"key":"6218_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/S11671-026-04665-9","volume":"21","author":"RA Hassan","year":"2026","unstructured":"Hassan RA, Al-Amrani WA, Alwany AB, Obaid JMAS (2026) Current advancements and future research directions in the green synthesis and applications of nanoparticles. Discover Nano 21:200. https:\/\/doi.org\/10.1186\/S11671-026-04665-9","journal-title":"Discover Nano"},{"key":"6218_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ASIA.202400701;WGROUP:STRING:PUBLICATION","volume":"19","author":"K Jain","year":"2024","unstructured":"Jain K, Takuli A, Gupta TK, Gupta D (2024) Rethinking nanoparticle synthesis: a sustainable approach vs. traditional methods Chem Asian J 19:e202400701. https:\/\/doi.org\/10.1002\/ASIA.202400701;WGROUP:STRING:PUBLICATION","journal-title":"traditional methods Chem Asian J"},{"key":"6218_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jmcb\/mjaa075","volume":"13","author":"MC Hardenberg","year":"2021","unstructured":"Hardenberg MC, Sinnige T, Casford S et al (2021) Observation of an \u03b1-synuclein liquid droplet state and its maturation into Lewy body-like assemblies. J Mol Cell Biol 13:282\u2013294. https:\/\/doi.org\/10.1093\/jmcb\/mjaa075","journal-title":"J Mol Cell Biol"},{"key":"6218_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41401-019-0304-y","volume":"41","author":"M-M Xu","year":"2020","unstructured":"Xu M-M, Ryan P, Rudrawar S et al (2020) Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein. Acta Pharmacol Sin 41:483\u2013498. https:\/\/doi.org\/10.1038\/s41401-019-0304-y","journal-title":"Acta Pharmacol Sin"},{"key":"6218_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/B978-0-12-819410-2.00008-4","volume":"184","author":"G Marino","year":"2022","unstructured":"Marino G, Calabresi P, Ghiglieri V (2022) Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease. Handb Clin Neurol 184:153\u2013166. https:\/\/doi.org\/10.1016\/B978-0-12-819410-2.00008-4","journal-title":"Handb Clin Neurol"},{"key":"6218_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020283","volume":"10","author":"DA Madsen","year":"2021","unstructured":"Madsen DA, Schmidt SI, Blaabjerg M, Meyer M (2021) Interaction between Parkin and \u03b1-Synuclein in PARK2-mediated Parkinson\u2019s disease. Cells 10:10.3390\/cells10020283","journal-title":"Cells"},{"key":"6218_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06251-8","volume":"14","author":"O Lurette","year":"2023","unstructured":"Lurette O, Mart\u00edn-Jim\u00e9nez R, Khan M et al (2023) Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization. Cell Death Dis 14:729. https:\/\/doi.org\/10.1038\/s41419-023-06251-8","journal-title":"Cell Death Dis"},{"key":"6218_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00930","volume":"13","author":"D Valdinocci","year":"2019","unstructured":"Valdinocci D, Sim\u00f5es RF, Kovarova J et al (2019) Intracellular and intercellular mitochondrial dynamics in Parkinson\u2019s disease. Front Neurosci 13:930. https:\/\/doi.org\/10.3389\/fnins.2019.00930","journal-title":"Front Neurosci"},{"key":"6218_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10072-018-3585-x","volume":"40","author":"R Kaur","year":"2019","unstructured":"Kaur R, Mehan S, Singh S (2019) Understanding multifactorial architecture of Parkinson\u2019s disease: pathophysiology to management. Neurol Sci 40:13\u201323. https:\/\/doi.org\/10.1007\/s10072-018-3585-x","journal-title":"Neurol Sci"},{"key":"6218_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S1875-5364(24)60652-7","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang Y, Che Y, Fang M et al (2024) Reynosin protects neuronal cells from microglial neuroinflammation by suppressing NLRP3 inflammasome activation mediated by NADPH oxidase. Chin J Nat Med 22:486\u2013500. https:\/\/doi.org\/10.1016\/S1875-5364(24)60652-7","journal-title":"Chin J Nat Med"},{"key":"6218_CR38","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.celrep.2015.08.001","volume":"12","author":"F-L Tang","year":"2015","unstructured":"Tang F-L, Liu W, Hu J-X et al (2015) VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function. Cell Rep 12:1631\u20131643. https:\/\/doi.org\/10.1016\/j.celrep.2015.08.001","journal-title":"Cell Rep"},{"key":"6218_CR39","doi-asserted-by":"publisher","first-page":"E7193","DOI":"10.1073\/pnas.1716506115","volume":"115","author":"J He","year":"2018","unstructured":"He J, Xia M, Yeung PKK et al (2018) PICK1 inhibits the E3 ubiquitin ligase activity of Parkin and reduces its neuronal protective effect. Proc Natl Acad Sci U S A 115:E7193\u2013E7201. https:\/\/doi.org\/10.1073\/pnas.1716506115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6218_CR40","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/c9bm00907h","volume":"7","author":"L Wang","year":"2019","unstructured":"Wang L, You X, Lou Q et al (2019) Cysteine-based redox-responsive nanoparticles for small-molecule agent delivery. Biomater Sci 7:4218\u20134229. https:\/\/doi.org\/10.1039\/c9bm00907h","journal-title":"Biomater Sci"},{"key":"6218_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92447-x","volume":"11","author":"E Kucuksayan","year":"2021","unstructured":"Kucuksayan E, Bozkurt F, Yilmaz MT et al (2021) A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers. Sci Rep 11:13027. https:\/\/doi.org\/10.1038\/s41598-021-92447-x","journal-title":"Sci Rep"},{"key":"6218_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122480","volume":"340","author":"MM Ansari","year":"2024","unstructured":"Ansari MM, Jori C, Ahmad A et al (2024) Oral delivery of aescin-loaded gelatin nanoparticles ameliorates carbon tetrachloride-induced hepatotoxicity in Wistar rats. Life Sci 340:122480. https:\/\/doi.org\/10.1016\/j.lfs.2024.122480","journal-title":"Life Sci"},{"key":"6218_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216711","volume":"14","author":"X Lin","year":"2019","unstructured":"Lin X, Bai D, Wei Z et al (2019) Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS ONE 14:e0216711. https:\/\/doi.org\/10.1371\/journal.pone.0216711","journal-title":"PLoS ONE"},{"key":"6218_CR44","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.2c06981","author":"W Wang","year":"2022","unstructured":"Wang W, Zheng J, Zhou H et al (2022) Polydopamine-based nanocomposite as a biomimetic antioxidant with a variety of enzymatic activities for Parkinson\u2019s disease. ACS Appl Mater Interfaces. https:\/\/doi.org\/10.1021\/acsami.2c06981","journal-title":"ACS Appl Mater Interfaces"},{"key":"6218_CR45","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1007\/s11064-018-2652-2","volume":"43","author":"S Darabi","year":"2018","unstructured":"Darabi S, Noori-Zadeh A, Rajaei F et al (2018) SMER28 attenuates dopaminergic toxicity mediated by 6-hydroxydopamine in the rats via modulating oxidative burdens and autophagy-related parameters. Neurochem Res 43:2313\u20132323. https:\/\/doi.org\/10.1007\/s11064-018-2652-2","journal-title":"Neurochem Res"},{"key":"6218_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pbb.2015.09.013","volume":"138","author":"J Wang","year":"2015","unstructured":"Wang J, He C, Wu W-Y et al (2015) Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson\u2019s disease. Pharmacol Biochem Behav 138:96\u2013103. https:\/\/doi.org\/10.1016\/j.pbb.2015.09.013","journal-title":"Pharmacol Biochem Behav"},{"key":"6218_CR47","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10517-018-4167-x","volume":"165","author":"IV Babenkova","year":"2018","unstructured":"Babenkova IV, Osipov AN, Teselkin YO (2018) The effect of dihydroquercetin on catalytic activity of iron (II) ions in the Fenton reaction. Bull Exp Biol Med 165:347\u2013350. https:\/\/doi.org\/10.1007\/s10517-018-4167-x","journal-title":"Bull Exp Biol Med"},{"key":"6218_CR48","doi-asserted-by":"publisher","first-page":"16286","DOI":"10.1021\/acsnano.1c05451","volume":"15","author":"Y Guo","year":"2021","unstructured":"Guo Y, Xu Y, Bao Q et al (2021) Endogenous copper for nanocatalytic oxidative damage and self-protection pathway breakage of cancer. ACS Nano 15:16286\u201316297. https:\/\/doi.org\/10.1021\/acsnano.1c05451","journal-title":"ACS Nano"},{"key":"6218_CR49","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1007\/s11064-021-03434-7","volume":"46","author":"Z Elmazoglu","year":"2021","unstructured":"Elmazoglu Z, Kayhan H, Santamar\u00eda A et al (2021) Platinum nanoparticles protect against lipopolysaccharide-induced inflammation in microglial BV-2 cells via decreased oxidative damage and increased phagocytosis. Neurochem Res 46:3325\u20133341. https:\/\/doi.org\/10.1007\/s11064-021-03434-7","journal-title":"Neurochem Res"},{"key":"6218_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abo4457","volume":"16","author":"JM Quiles","year":"2023","unstructured":"Quiles JM, Najor RH, Gonzalez E et al (2023) Deciphering functional roles and interplay between Beclin1 and Beclin2 in autophagosome formation and mitophagy. Sci Signal 16:eabo4457. https:\/\/doi.org\/10.1126\/scisignal.abo4457","journal-title":"Sci Signal"},{"key":"6218_CR51","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1080\/15548627.2021.1984656","volume":"18","author":"J Zhou","year":"2022","unstructured":"Zhou J, Li XY, Liu YJ et al (2022) Full-coverage regulations of autophagy by ROS: from induction to maturation. Autophagy 18:1240\u20131255. https:\/\/doi.org\/10.1080\/15548627.2021.1984656","journal-title":"Autophagy"},{"key":"6218_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19420889.2018.1467189","volume":"11","author":"M Bansal","year":"2018","unstructured":"Bansal M, Moharir SC, Swarup G (2018) Autophagy receptor optineurin promotes autophagosome formation by potentiating LC3-II production and phagophore maturation. Commun Integr Biol 11:1\u20134. https:\/\/doi.org\/10.1080\/19420889.2018.1467189","journal-title":"Commun Integr Biol"},{"key":"6218_CR53","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1080\/15548627.2024.2386915","volume":"20","author":"F Wei","year":"2024","unstructured":"Wei F, Wang Y, Yao J et al (2024) ZDHHC7-mediated S-palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation. Autophagy 20:2719\u20132737. https:\/\/doi.org\/10.1080\/15548627.2024.2386915","journal-title":"Autophagy"},{"key":"6218_CR54","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/15548627.2016.1140293","volume":"12","author":"J-M Park","year":"2016","unstructured":"Park J-M, Jung CH, Seo M et al (2016) The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14. Autophagy 12:547\u2013564. https:\/\/doi.org\/10.1080\/15548627.2016.1140293","journal-title":"Autophagy"},{"key":"6218_CR55","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jnc.13412","volume":"136","author":"D Ivankovic","year":"2016","unstructured":"Ivankovic D, Chau K-Y, Schapira AHV, Gegg ME (2016) Mitochondrial and lysosomal biogenesis are activated following PINK1\/parkin-mediated mitophagy. J Neurochem 136:388\u2013402. https:\/\/doi.org\/10.1111\/jnc.13412","journal-title":"J Neurochem"},{"key":"6218_CR56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10863-017-9727-7","volume":"49","author":"H Liu","year":"2017","unstructured":"Liu H, Dai C, Fan Y et al (2017) From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases. J Bioenerg Biomembr 49:413\u2013422. https:\/\/doi.org\/10.1007\/s10863-017-9727-7","journal-title":"J Bioenerg Biomembr"},{"key":"6218_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179220","author":"LP Perez-Abshana","year":"2024","unstructured":"Perez-Abshana LP, Mendivil-Perez M, Jimenez-Del-Rio M, Velez-Pardo C (2024) The GBA1 K198E variant is associated with suppression of glucocerebrosidase activity, autophagy impairment, oxidative stress, mitochondrial damage, and apoptosis in skin fibroblasts. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25179220","journal-title":"Int J Mol Sci"},{"key":"6218_CR58","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1093\/hmg\/ddw185","volume":"25","author":"J Magalhaes","year":"2016","unstructured":"Magalhaes J, Gegg ME, Migdalska-Richards A et al (2016) Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease. Hum Mol Genet 25:3432\u20133445. https:\/\/doi.org\/10.1093\/hmg\/ddw185","journal-title":"Hum Mol Genet"},{"key":"6218_CR59","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1021\/acschemneuro.6b00207","volume":"7","author":"P Kundu","year":"2016","unstructured":"Kundu P, Das M, Tripathy K, Sahoo SK (2016) Delivery of dual drug loaded lipid based nanoparticles across the blood-brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of Parkinson\u2019s disease. ACS Chem Neurosci 7:1658\u20131670. https:\/\/doi.org\/10.1021\/acschemneuro.6b00207","journal-title":"ACS Chem Neurosci"},{"key":"6218_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1049\/nbt2.12127","volume":"17","author":"C Jalili","year":"2023","unstructured":"Jalili C, Kiani A, Gholami M et al (2023) Brain targeting based nanocarriers loaded with resveratrol in Alzheimer\u2019s disease: a review. IET Nanobiotechnol 17:154\u2013170. https:\/\/doi.org\/10.1049\/nbt2.12127","journal-title":"IET Nanobiotechnol"},{"key":"6218_CR61","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.2c00706","author":"AS Rathore","year":"2023","unstructured":"Rathore AS, Singh SS, Birla H et al (2023) Curcumin modulates p62-Keap1-Nrf2-mediated autophagy in rotenone-induced Parkinson\u2019s disease mouse models. ACS Chem Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.2c00706","journal-title":"ACS Chem Neurosci"},{"key":"6218_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2327-5146.1000207","volume":"3","author":"M D\u00edaz","year":"2015","unstructured":"D\u00edaz M, Vaamonde L, Dajas F (2015) Assessment of the protective capacity of nanosomes of quercetin in an experimental model of parkinsons disease in the rat. Gen Med (Los Angel) 3:2","journal-title":"Gen Med (Los Angel)"},{"key":"6218_CR63","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/S13346-024-01656-0","volume":"15","author":"A Bandiwadekar","year":"2025","unstructured":"Bandiwadekar A, Jose J, Gopan G et al (2025) Transdermal delivery of resveratrol loaded solid lipid nanoparticle as a microneedle patch: a novel approach for the treatment of Parkinson\u2019s disease. Drug Deliv Transl Res 15:1043\u20131073. https:\/\/doi.org\/10.1007\/S13346-024-01656-0","journal-title":"Drug Deliv Transl Res"},{"key":"6218_CR64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10561-022-10008-6","volume":"24","author":"M Mobahat","year":"2023","unstructured":"Mobahat M, Sadroddiny E, Nooshabadi VT et al (2023) Curcumin-loaded human endometrial stem cells derived exosomes as an effective carrier to suppress alpha-synuclein aggregates in 6OHDA-induced Parkinson\u2019s disease mouse model. Cell Tissue Bank 24:75\u201391. https:\/\/doi.org\/10.1007\/s10561-022-10008-6","journal-title":"Cell Tissue Bank"},{"key":"6218_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102438","volume":"58","author":"Y Xu","year":"2024","unstructured":"Xu Y, Yan G, Zhao J et al (2024) Plant-derived exosomes as cell homogeneous nanoplatforms for brain biomacromolecules delivery ameliorate mitochondrial dysfunction against Parkinson\u2019s disease. Nano Today 58:102438","journal-title":"Nano Today"},{"key":"6218_CR66","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ijbiomac.2022.01.116","volume":"203","author":"M Parveen","year":"2022","unstructured":"Parveen M, Kumar A, Khan MS et al (2022) Comparative study of biogenically synthesized silver and gold nanoparticles of Acacia auriculiformis leaves and their efficacy against Alzheimer\u2019s and Parkinson\u2019s disease. Int J Biol Macromol 203:292\u2013301. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.116","journal-title":"Int J Biol Macromol"},{"key":"6218_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012699","volume":"23","author":"D Mendes","year":"2022","unstructured":"Mendes D, Peixoto F, Oliveira MM et al (2022) Brain effects of SC-Nanophytosomes on a rotenone-induced rat model of Parkinson\u2019s disease-A proof of concept for a mitochondria-targeted therapy. Int J Mol Sci 23:12699. https:\/\/doi.org\/10.3390\/ijms232012699","journal-title":"Int J Mol Sci"},{"key":"6218_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2019.111635","volume":"200","author":"J Xue","year":"2019","unstructured":"Xue J, Liu T, Liu Y et al (2019) Neuroprotective effect of biosynthesised gold nanoparticles synthesised from root extract of Paeonia moutan against Parkinson disease - in vitro & In vivo model. J Photochem Photobiol B 200:111635. https:\/\/doi.org\/10.1016\/j.jphotobiol.2019.111635","journal-title":"J Photochem Photobiol B"},{"key":"6218_CR69","doi-asserted-by":"crossref","unstructured":"Shivanna DK (2022) Datura Stramonium leaves extract silver nanoparticles regulates PINK1 gene in Parkinson \u2019 s disease model of Drosophila melanogaster. Res Sq 1\u201316","DOI":"10.21203\/rs.3.rs-1807001\/v1"},{"key":"6218_CR70","doi-asserted-by":"publisher","unstructured":"Rajput MS, Nirmal NP, Patel V, et al (2023) Phytoconstituents-based nanoformulations for neurodegenerative disorders. Recent Frontiers of Phytochemicals: Applications in Food, Pharmacy, Cosmetics, and Biotechnology 463\u2013482. https:\/\/doi.org\/10.1016\/B978-0-443-19143-5.00003-7","DOI":"10.1016\/B978-0-443-19143-5.00003-7"},{"key":"6218_CR71","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1590\/S1984-82502014000400022","volume":"50","author":"N Gulati","year":"2014","unstructured":"Gulati N, Nagaich U, Saraf S (2014) Fabrication and in vitro characterization of polymeric nanoparticles for Parkinson\u2019s therapy: a novel approach. Braz J Pharm Sci 50:869\u2013876","journal-title":"Braz J Pharm Sci"},{"key":"6218_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.7208","volume":"37","author":"N Sher","year":"2023","unstructured":"Sher N, Ahmed M, Mushtaq N, Khan RA (2023) Antioxidant, antidiabetic, and anti-Alzheimer performance of green synthesized silver, gold, and silver\/gold bimetallic nanoparticles. Appl Organomet Chem 37:e7208","journal-title":"Appl Organomet Chem"},{"key":"6218_CR73","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s13346-023-01407-7","volume":"14","author":"DM Hassan","year":"2024","unstructured":"Hassan DM, El-Kamel AH, Allam EA et al (2024) Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson\u2019s disease: interplay between nuclear factor-kappa \u03b2 and cathepsin B. Drug Deliv Transl Res 14:400\u2013417","journal-title":"Drug Deliv Transl Res"},{"key":"6218_CR74","doi-asserted-by":"publisher","unstructured":"Khot KB, Gopan G, Bandiwadekar A, Jose J (2023) Current advancements related to phytobioactive compounds based liposomal delivery for neurodegenerative diseases. Ageing Res Rev 83:. https:\/\/doi.org\/10.1016\/J.ARR.2022.101806","DOI":"10.1016\/J.ARR.2022.101806"},{"key":"6218_CR75","doi-asserted-by":"publisher","first-page":"8804","DOI":"10.1021\/ACSOMEGA.9B00304","volume":"4","author":"R Kanwar","year":"2019","unstructured":"Kanwar R, Rathee J, Salunke DB, Mehta SK (2019) Green nanotechnology-driven drug delivery assemblies. ACS Omega 4:8804\u20138815. https:\/\/doi.org\/10.1021\/ACSOMEGA.9B00304","journal-title":"ACS Omega"},{"key":"6218_CR76","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejps.2017.05.060","volume":"106","author":"LNM Ribeiro","year":"2017","unstructured":"Ribeiro LNM, Breitkreitz MC, Guilherme VA et al (2017) Natural lipids-based NLC containing lidocaine: from pre-formulation to in vivo studies. Eur J Pharm Sci 106:102\u2013112. https:\/\/doi.org\/10.1016\/j.ejps.2017.05.060","journal-title":"Eur J Pharm Sci"},{"key":"6218_CR77","doi-asserted-by":"publisher","first-page":"804","DOI":"10.2174\/0122117385305245240424093014","volume":"13","author":"S Dutta","year":"2025","unstructured":"Dutta S, Ghosh S, Rahaman M, Chowdhary SR (2025) Plant-derived exosomes: pioneering breakthroughs in therapeutics, targeted drug delivery, and regenerative medicine. Pharm Nanotechnol 13:804\u2013826. https:\/\/doi.org\/10.2174\/0122117385305245240424093014","journal-title":"Pharm Nanotechnol"},{"key":"6218_CR78","doi-asserted-by":"publisher","DOI":"10.3892\/IJMM.2023.5253","author":"Z Ma","year":"2023","unstructured":"Ma Z, Liang H, Hu B et al (2023) Autophagy-regulating miRNAs: novel therapeutic targets for Parkinson\u2019s disease (review). Int J Mol Med. https:\/\/doi.org\/10.3892\/IJMM.2023.5253","journal-title":"Int J Mol Med"},{"key":"6218_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314997","author":"D Minchev","year":"2022","unstructured":"Minchev D, Kazakova M, Sarafian V (2022) Neuroinflammation and autophagy in Parkinson\u2019s disease\u2014novel perspectives. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232314997","journal-title":"Int J Mol Sci"},{"key":"6218_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/ACEL.13584","author":"ML Arotcarena","year":"2022","unstructured":"Arotcarena ML, Soria FN, Cunha A et al (2022) Acidic nanoparticles protect against \u03b1-synuclein-induced neurodegeneration through the restoration of lysosomal function. Aging Cell. https:\/\/doi.org\/10.1111\/ACEL.13584","journal-title":"Aging Cell"},{"key":"6218_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOADV.2024.214065","volume":"166","author":"JT Yang","year":"2025","unstructured":"Yang JT, Kuo YC, Lee KC et al (2025) Resveratrol and ceftriaxone encapsulated in hybrid nanoparticles to prevent dopaminergic neurons from degeneration for Parkinson\u2019s disease treatment. Biomater Adv 166:214065. https:\/\/doi.org\/10.1016\/J.BIOADV.2024.214065","journal-title":"Biomater Adv"},{"issue":"1","key":"6218_CR82","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/S12951-024-02526-0","volume":"22","author":"A Tapia-Arellano","year":"2024","unstructured":"Tapia-Arellano A, Cabrera P, Cort\u00e9s-Adasme E et al (2024) Tau- and \u03b1-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases. J Nanobiotechnol 22(1):22\u2013248. https:\/\/doi.org\/10.1186\/S12951-024-02526-0","journal-title":"J Nanobiotechnol"},{"key":"6218_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/J.ONANO.2023.100140","volume":"11","author":"DE Igart\u00faa","year":"2023","unstructured":"Igart\u00faa DE, Gonz\u00e1lez-Liz\u00e1rraga F, Martinez CS et al (2023) PAMAM dendrimers of generation 4.5 loaded with curcumin interfere with \u03b1-synuclein aggregation. OpenNano 11:100140. https:\/\/doi.org\/10.1016\/J.ONANO.2023.100140","journal-title":"OpenNano"},{"key":"6218_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118391","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou J, Zhuo L et al (2024) The TLR4\/NF-\u03baB\/NLRP3 and Nrf2\/HO-1 pathways mediate the neuroprotective effects of alkaloids extracted from Uncaria rhynchophylla in Parkinson\u2019s disease. J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2024.118391","journal-title":"J Ethnopharmacol"},{"key":"6218_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2021.757161\/FULL","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Gao L, Chen J et al (2021) Pharmacological modulation of Nrf2\/HO-1 signaling pathway as a therapeutic target of Parkinson\u2019s disease. Front Pharmacol 12:757161. https:\/\/doi.org\/10.3389\/FPHAR.2021.757161\/FULL","journal-title":"Front Pharmacol"},{"issue":"2","key":"6218_CR86","doi-asserted-by":"publisher","DOI":"10.1007\/S11064-026-04749-Z","volume":"51","author":"IMM Teixeira","year":"2026","unstructured":"Teixeira IMM, Duque BR, da Costa MDR et al (2026) Resveratrol-loaded polymeric nanoparticles protect against rotenone-induced Parkinsonian-like cellular damage in vitro: association with NRF2\/HMOX-1 expression changes. Neurochem Res 51(2):138. https:\/\/doi.org\/10.1007\/S11064-026-04749-Z","journal-title":"Neurochem Res"},{"key":"6218_CR87","doi-asserted-by":"publisher","DOI":"10.1074\/JBC.REV120.014294","volume":"296","author":"EH Clark","year":"2020","unstructured":"Clark EH, de la Torre AV, Hoshikawa T, Briston T (2020) Targeting mitophagy in Parkinson\u2019s disease. J Biol Chem 296:100209. https:\/\/doi.org\/10.1074\/JBC.REV120.014294","journal-title":"J Biol Chem"},{"key":"6218_CR88","doi-asserted-by":"publisher","first-page":"17979","DOI":"10.1021\/ACSNANO.3C04308\/SUPPL_FILE\/NN3C04308_SI_003.MP4","volume":"17","author":"X Xia","year":"2023","unstructured":"Xia X, Li H, Xu X et al (2023) Facilitating pro-survival mitophagy for alleviating Parkinson\u2019s disease via sequence-targeted lycopene nanodots. ACS Nano 17:17979\u201317995. https:\/\/doi.org\/10.1021\/ACSNANO.3C04308\/SUPPL_FILE\/NN3C04308_SI_003.MP4","journal-title":"ACS Nano"},{"key":"6218_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS15031006","volume":"15","author":"A Iranpanah","year":"2023","unstructured":"Iranpanah A, Kooshki L, Moradi SZ et al (2023) The exosome-mediated PI3K\/Akt\/mTOR signaling pathway in neurological diseases. Pharmaceutics 15:1006. https:\/\/doi.org\/10.3390\/PHARMACEUTICS15031006","journal-title":"Pharmaceutics"},{"key":"6218_CR90","doi-asserted-by":"publisher","first-page":"43379","DOI":"10.1021\/ACSOMEGA.5C06298","volume":"10","author":"Y Cao","year":"2025","unstructured":"Cao Y, Li H, Jiang H et al (2025) Research progress on regulating autophagy in traditional Chinese medicine for the treatment of traumatic brain injury. ACS Omega 10:43379\u201343390. https:\/\/doi.org\/10.1021\/ACSOMEGA.5C06298","journal-title":"ACS Omega"},{"issue":"5","key":"6218_CR91","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1007\/S12035-024-04608-4","volume":"62","author":"BK Utpal","year":"2024","unstructured":"Utpal BK, Mokhfi FZ, Zehravi M et al (2024) Resveratrol: a natural compound targeting the PI3K\/Akt\/mTOR pathway in neurological diseases. Mol Neurobiol 62(5):5579\u20135608. https:\/\/doi.org\/10.1007\/S12035-024-04608-4","journal-title":"Mol Neurobiol"},{"issue":"1","key":"6218_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/S12951-024-02587-1","volume":"22","author":"T Lei","year":"2024","unstructured":"Lei T, Li C, Liu Y et al (2024) Microfluidics-enabled mesenchymal stem cell derived neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson\u2019s disease. J Nanobiotechnol 22(1):370. https:\/\/doi.org\/10.1186\/S12951-024-02587-1","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"6218_CR93","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6680935","volume":"2021","author":"R Balakrishnan","year":"2021","unstructured":"Balakrishnan R, Azam S, Cho DY et al (2021) Natural phytochemicals as novel therapeutic strategies to prevent and treat Parkinson\u2019s disease: current knowledge and future perspectives. Oxid Med Cell Longev 6680935. https:\/\/doi.org\/10.1155\/2021\/6680935","journal-title":"Oxid Med Cell Longev"},{"key":"6218_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS232213886","volume":"23","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang K, Yan J et al (2022) Recent progress in research on mechanisms of action of natural products against Alzheimer\u2019s disease: dietary plant polyphenols. Int J Mol Sci 23:13886. https:\/\/doi.org\/10.3390\/IJMS232213886","journal-title":"Int J Mol Sci"},{"key":"6218_CR95","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1021\/ACSAMI.4C14809","volume":"17","author":"J Chen","year":"2025","unstructured":"Chen J, Zha H, Xu M et al (2025) Zebrafish as a visible neuroinflammation model for evaluating the anti-inflammation effect of curcumin-loaded ferritin nanoparticles. ACS Appl Mater Interfaces 17:4450\u20134462. https:\/\/doi.org\/10.1021\/ACSAMI.4C14809","journal-title":"ACS Appl Mater Interfaces"},{"key":"6218_CR96","doi-asserted-by":"publisher","first-page":"13707","DOI":"10.1007\/S12035-025-05148-1","volume":"62","author":"E Asani","year":"2025","unstructured":"Asani E, Hatami H, Hamidian G, Hatami S (2025) Investigating the effects of niosome curcumin on the alteration of NF-\u03baB gene expression and memory and learning in the prefrontal cortex of Alzheimer\u2019s rats. Mol Neurobiol 62:13707\u201313721. https:\/\/doi.org\/10.1007\/S12035-025-05148-1","journal-title":"Mol Neurobiol"},{"key":"6218_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJN.S570452","volume":"21","author":"X Yin","year":"2026","unstructured":"Yin X, Wang C, Lin W et al (2026) Nanotherapeutic interventions for Parkinson\u2019s disease: modulating pathogenic mechanisms and overcoming therapeutic obstacles. Int J Nanomedicine 21:1\u201339. https:\/\/doi.org\/10.2147\/IJN.S570452","journal-title":"Int J Nanomedicine"},{"key":"6218_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/J.CEJ.2023.141606","volume":"461","author":"L Lei","year":"2023","unstructured":"Lei L, Tu Q, Zhang X et al (2023) Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson\u2019s disease by modulating \u03b1-synuclein aggregation and reactive oxygen species. Chem Eng J 461:141606. https:\/\/doi.org\/10.1016\/J.CEJ.2023.141606","journal-title":"Chem Eng J"},{"key":"6218_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DDDT.S566113","volume":"20","author":"R Mu","year":"2026","unstructured":"Mu R, Liu T, Zhang Y et al (2026) Therapeutic efficacy of curcumin nanoparticles in Parkinson&rsquo;s disease: an integrated analysis of network pharmacology, experimental validation, and gut microbiota. Drug Des Devel Ther 20:1\u201321. https:\/\/doi.org\/10.2147\/DDDT.S566113","journal-title":"Drug Des Devel Ther"},{"key":"6218_CR100","doi-asserted-by":"publisher","unstructured":"Nurohman I, Suhandi C, Chaerunisaa AY, et al (2026) Design evolution of curcumin-loaded nanostructured lipid carriers: formulation strategies, functional modifications, and mechanistic\u2013translational perspectives. Int J Nanomedicine 21:. https:\/\/doi.org\/10.2147\/IJN.S586727","DOI":"10.2147\/IJN.S586727"},{"key":"6218_CR101","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/17425247.2026.2628612","volume":"23","author":"NN Porfiryeva","year":"2026","unstructured":"Porfiryeva NN, Moustafine RI, Khutoryanskiy VV (2026) Advances in mucoadhesive and mucus-penetrating materials, nano-formulations, and in situ gelling systems for nasal drug delivery. Expert Opin Drug Deliv 23:797\u2013822. https:\/\/doi.org\/10.1080\/17425247.2026.2628612","journal-title":"Expert Opin Drug Deliv"},{"key":"6218_CR102","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/PHARMACEUTICS16040481","volume":"16","author":"S Gandhi","year":"2024","unstructured":"Gandhi S, Shastri DH, Shah J et al (2024) Nasal delivery to the brain: harnessing nanoparticles for effective drug transport. Pharmaceutics 16:481. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16040481","journal-title":"Pharmaceutics"},{"issue":"1","key":"6218_CR103","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/S13064-026-00258-5","volume":"21","author":"J Banyyounes","year":"2026","unstructured":"Banyyounes J, Obeid MA (2026) Approaches for the delivery of anti-parkinsonian therapeutic agents via the intranasal route. Discover Neuroscience 21(1):28. https:\/\/doi.org\/10.1186\/S13064-026-00258-5","journal-title":"Discover Neuroscience"},{"key":"6218_CR104","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1021\/ACS.MOLPHARMACEUT.1C00366","volume":"18","author":"AR Clementino","year":"2021","unstructured":"Clementino AR, Pellegrini G, Banella S et al (2021) Structure and fate of nanoparticles designed for the nasal delivery of poorly soluble drugs. Mol Pharm 18:3132\u20133146. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.1C00366","journal-title":"Mol Pharm"},{"key":"6218_CR105","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1039\/D4NR04250F","volume":"17","author":"S Sharma","year":"2025","unstructured":"Sharma S, Gauba P, Tyagi A, Dang S (2025) Chitosan-modified polymeric nanoparticles for the nose-to-brain drug delivery of paroxetine: an in vitro and in vivo evaluation. Nanoscale 17:1687\u20131702. https:\/\/doi.org\/10.1039\/D4NR04250F","journal-title":"Nanoscale"},{"key":"6218_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS16030329","author":"E Agosti","year":"2024","unstructured":"Agosti E, Zeppieri M, Antonietti S et al (2024) Navigating the nose-to-brain route: a systematic review on lipid-based nanocarriers for central nervous system disorders. Pharmaceutics (Basel). https:\/\/doi.org\/10.3390\/PHARMACEUTICS16030329","journal-title":"Pharmaceutics (Basel)"},{"key":"6218_CR107","doi-asserted-by":"publisher","DOI":"10.1208\/S12249-025-03185-6","author":"K Aggarwal","year":"2025","unstructured":"Aggarwal K, Joshi S, Jindal P et al (2025) Solid lipid nanoparticles: an innovative drug delivery system for enhanced bioavailability and targeted therapy. AAPS PharmSciTech. https:\/\/doi.org\/10.1208\/S12249-025-03185-6","journal-title":"AAPS PharmSciTech"},{"key":"6218_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2026.126604","volume":"692","author":"YD Geremamo","year":"2026","unstructured":"Geremamo YD, Hasan A, Razzak SA, Uddin S (2026) Unlocking the potential of lipid-based nanoparticles for intranasal drug delivery in Parkinson\u2019s disease. Int J Pharm 692:126604. https:\/\/doi.org\/10.1016\/J.IJPHARM.2026.126604","journal-title":"Int J Pharm"},{"key":"6218_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/WNAN.1898;WEBSITE:WEBSITE:WIRES;WGROUP:STRING:PUBLICATION","volume":"15","author":"S Hernando","year":"2023","unstructured":"Hernando S, Santos-Vizca\u00edno E, Igartua M, Hernandez RM (2023) Targeting the central nervous system: from synthetic nanoparticles to extracellular vesicles\u2014focus on Alzheimer\u2019s and Parkinson\u2019s disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol 15:e1898. https:\/\/doi.org\/10.1002\/WNAN.1898;WEBSITE:WEBSITE:WIRES;WGROUP:STRING:PUBLICATION","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"6218_CR110","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/IJN.S347187","volume":"17","author":"S Fakhri","year":"2022","unstructured":"Fakhri S, Abdian S, Zarneshan SN et al (2022) Nanoparticles in combating neuronal dysregulated signaling pathways: recent approaches to the nanoformulations of phytochemicals and synthetic drugs against neurodegenerative diseases. Int J Nanomedicine 17:299\u2013331. https:\/\/doi.org\/10.2147\/IJN.S347187","journal-title":"Int J Nanomedicine"},{"key":"6218_CR111","doi-asserted-by":"publisher","first-page":"1637589","DOI":"10.3389\/FBIOE.2025.1637589\/FULL","volume":"13","author":"S Singaravelu","year":"2025","unstructured":"Singaravelu S, Motsoene F, Abrahamse H, Dhilip Kumar SS (2025) Green-synthesized metal nanoparticles: a promising approach for accelerated wound healing. Front Bioeng Biotechnol 13:1637589. https:\/\/doi.org\/10.3389\/FBIOE.2025.1637589\/FULL","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"6218_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S44475-025-00003-2","volume":"1","author":"SM Abegunde","year":"2025","unstructured":"Abegunde SM, Alaka MO, Awonyemi OI (2025) Nanomaterial toxicity: a comprehensive review of mechanisms and mitigation strategies. Discover Hazards 1(1):1\u20133. https:\/\/doi.org\/10.1007\/S44475-025-00003-2","journal-title":"Discover Hazards"},{"key":"6218_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIOX14040489","author":"D Batir-Marin","year":"2025","unstructured":"Batir-Marin D, Boev M, Cioanca O et al (2025) Exploring oxidative stress mechanisms of nanoparticles using zebrafish (Danio rerio): toxicological and pharmaceutical insights. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/ANTIOX14040489","journal-title":"Antioxidants (Basel)"},{"key":"6218_CR114","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/MP800051M","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505\u2013515. https:\/\/doi.org\/10.1021\/MP800051M","journal-title":"Mol Pharm"},{"key":"6218_CR115","doi-asserted-by":"publisher","unstructured":"Weaver JL, Tobin GA, Ingle T, et al (2017) Evaluating the potential of gold, silver, and silica nanoparticles to saturate mononuclear phagocytic system tissues under repeat dosing conditions. Particle and Fibre Toxicology 2017 14:1 14:25-. https:\/\/doi.org\/10.1186\/S12989-017-0206-4","DOI":"10.1186\/S12989-017-0206-4"},{"key":"6218_CR116","doi-asserted-by":"publisher","unstructured":"Hanson LR, William H Frey I (2008) Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9:S5. https:\/\/doi.org\/10.1186\/1471-2202-9-S3-S5","DOI":"10.1186\/1471-2202-9-S3-S5"},{"key":"6218_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/J.COPBIO.2023.103010","author":"TT Tran","year":"2023","unstructured":"Tran TT, Roffler SR (2023) Interactions between nanoparticle corona proteins and the immune system. Curr Opin Biotechnol. https:\/\/doi.org\/10.1016\/J.COPBIO.2023.103010","journal-title":"Curr Opin Biotechnol"},{"key":"6218_CR118","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3390\/PHARMACEUTICS14122605","volume":"14","author":"S Panico","year":"2022","unstructured":"Panico S, Capolla S, Bozzer S et al (2022) Biological features of nanoparticles: protein corona formation and interaction with the immune system. Pharmaceutics 14:2605\u20132605. https:\/\/doi.org\/10.3390\/PHARMACEUTICS14122605","journal-title":"Pharmaceutics"},{"key":"6218_CR119","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/J.SMIM.2017.09.011","volume":"34","author":"Y Liu","year":"2017","unstructured":"Liu Y, Hardie J, Zhang X, Rotello VM (2017) Effects of engineered nanoparticles on the innate immune system. Semin Immunol 34:25. https:\/\/doi.org\/10.1016\/J.SMIM.2017.09.011","journal-title":"Semin Immunol"},{"key":"6218_CR120","doi-asserted-by":"publisher","unstructured":"Qiu Y, He T, Miao C, et al (2026) The distribution of complement proteins in soft and hard coronas impacts macrophage uptake of nanoparticles. Adv Healthc Mater 15:. https:\/\/doi.org\/10.1002\/ADHM.202503534","DOI":"10.1002\/ADHM.202503534"},{"key":"6218_CR121","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.2147\/IJN.S443168","volume":"19","author":"K Jakic","year":"2024","unstructured":"Jakic K, Selc M, Razga F et al (2024) Long-term accumulation, biological effects and toxicity of BSA-coated gold nanoparticles in the mouse liver, spleen, and kidneys. Int J Nanomedicine 19:4103\u20134120. https:\/\/doi.org\/10.2147\/IJN.S443168","journal-title":"Int J Nanomedicine"},{"key":"6218_CR122","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.2147\/IJN.S260375","volume":"16","author":"DF B\u00e1ez","year":"2021","unstructured":"B\u00e1ez DF, Gallardo-Toledo E, Oyarz\u00fan MP et al (2021) The influence of size and chemical composition of silver and gold nanoparticles on in vivo toxicity with potential applications to central nervous system diseases. Int J Nanomedicine 16:2187\u20132201. https:\/\/doi.org\/10.2147\/IJN.S260375","journal-title":"Int J Nanomedicine"},{"issue":"11","key":"6218_CR123","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/S10856-023-06753-Z","volume":"34","author":"K Wang","year":"2023","unstructured":"Wang K, Wang S, Yin J et al (2023) Long-term application of silver nanoparticles in dental restoration materials: potential toxic injury to the CNS. J Mater Sci Mater Med 34(11):34\u201352. https:\/\/doi.org\/10.1007\/S10856-023-06753-Z","journal-title":"J Mater Sci Mater Med"},{"issue":"1","key":"6218_CR124","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/S11419-021-00589-4","volume":"40","author":"A Janzadeh","year":"2021","unstructured":"Janzadeh A, Behroozi Z, saliminia F et al (2021) Neurotoxicity of silver nanoparticles in the animal brain: a systematic review and meta-analysis. Forensic Toxicol 40(1):49\u201363. https:\/\/doi.org\/10.1007\/S11419-021-00589-4","journal-title":"Forensic Toxicol"},{"key":"6218_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/J.JTEMIN.2025.100252","volume":"13","author":"R Kumar","year":"2025","unstructured":"Kumar R, Kumar A, Bhardwaj S et al (2025) Nanotoxicity unveiled: evaluating exposure risks and assessing the impact of nanoparticles on human health. J Trace Elem Miner 13:100252. https:\/\/doi.org\/10.1016\/J.JTEMIN.2025.100252","journal-title":"J Trace Elem Miner"},{"key":"6218_CR126","doi-asserted-by":"publisher","DOI":"10.1002\/MCO2.327","volume":"4","author":"L Xuan","year":"2023","unstructured":"Xuan L, Ju Z, Skonieczna M et al (2023) Nanoparticles-induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models. MedComm (Beijing) 4:e327. https:\/\/doi.org\/10.1002\/MCO2.327","journal-title":"MedComm (Beijing)"},{"key":"6218_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/J.ONANO.2023.100190","volume":"14","author":"HE Thu","year":"2023","unstructured":"Thu HE, Haider MA, Khan S et al (2023) Nanotoxicity induced by nanomaterials: a review of factors affecting nanotoxicity and possible adaptations. OpenNano 14:100190. https:\/\/doi.org\/10.1016\/J.ONANO.2023.100190","journal-title":"OpenNano"},{"key":"6218_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/J.JECE.2025.116921","volume":"13","author":"B Cardoso","year":"2025","unstructured":"Cardoso B, Nobrega G, Afonso IS et al (2025) Sustainable green synthesis of metallic nanoparticle using plants and microorganisms: a review of biosynthesis methods, mechanisms, toxicity, and applications. J Environ Chem Eng 13:116921. https:\/\/doi.org\/10.1016\/J.JECE.2025.116921","journal-title":"J Environ Chem Eng"},{"key":"6218_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCLEPRO.2021.129198","volume":"324","author":"JA Kumar","year":"2021","unstructured":"Kumar JA, Krithiga T, Manigandan S et al (2021) A focus to green synthesis of metal\/metal based oxide nanoparticles: various mechanisms and applications towards ecological approach. J Clean Prod 324:129198. https:\/\/doi.org\/10.1016\/J.JCLEPRO.2021.129198","journal-title":"J Clean Prod"},{"issue":"1","key":"6218_CR130","doi-asserted-by":"publisher","DOI":"10.1007\/S44509-026-00006-2","volume":"1","author":"SM Syed","year":"2026","unstructured":"Syed SM, Kulkarni S, Patil M, Satpute K (2026) A comprehensive review of green synthesis methods and applications of nanoparticles derived from plant extracts and microorganisms. Discov Green Chem 1(1):1:6-. https:\/\/doi.org\/10.1007\/S44509-026-00006-2","journal-title":"Discov Green Chem"},{"key":"6218_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLSTRUC.2021.131538","volume":"1248","author":"FE Ettadili","year":"2022","unstructured":"Ettadili FE, Aghris S, Laghrib F et al (2022) Recent advances in the nanoparticles synthesis using plant extract: applications and future recommendations. J Mol Struct 1248:131538. https:\/\/doi.org\/10.1016\/J.MOLSTRUC.2021.131538","journal-title":"J Mol Struct"},{"issue":"3","key":"6218_CR132","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","volume":"2","author":"H Cabral","year":"2023","unstructured":"Cabral H, Li J, Miyata K, Kataoka K (2023) Controlling the biodistribution and clearance of nanomedicines. Nat Rev Bioeng 2(3):214\u2013232. https:\/\/doi.org\/10.1038\/s44222-023-00138-1","journal-title":"Nat Rev Bioeng"},{"key":"6218_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2025.125202","volume":"671","author":"X Zhang","year":"2025","unstructured":"Zhang X, Chan HW, Shao Z et al (2025) Navigating translational research in nanomedicine: a strategic guide to formulation and manufacturing. Int J Pharm 671:125202. https:\/\/doi.org\/10.1016\/J.IJPHARM.2025.125202","journal-title":"Int J Pharm"},{"issue":"11","key":"6218_CR134","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","volume":"19","author":"P Joyce","year":"2024","unstructured":"Joyce P, Allen CJ, Alonso MJ et al (2024) A translational framework to deliver nanomedicines to the clinic. Nat Nanotechnol 19(11):1597\u20131611. https:\/\/doi.org\/10.1038\/s41565-024-01754-7","journal-title":"Nat Nanotechnol"},{"key":"6218_CR135","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1080\/17435889.2025.2533107","volume":"20","author":"B Mangla","year":"2025","unstructured":"Mangla B, Kumar P, Javed S et al (2025) Regulating nanomedicines: challenges, opportunities, and the path forward. Nanomedicine (Lond) 20:1911\u20131927. https:\/\/doi.org\/10.1080\/17435889.2025.2533107","journal-title":"Nanomedicine (Lond)"},{"key":"6218_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/FNANA.2014.00155\/FULL","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S (2014) Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat 8:123289. https:\/\/doi.org\/10.3389\/FNANA.2014.00155\/FULL","journal-title":"Front Neuroanat"},{"issue":"1","key":"6218_CR137","doi-asserted-by":"publisher","DOI":"10.1186\/S13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJM (2017) The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegener 12(1):10. https:\/\/doi.org\/10.1186\/S13024-017-0149-0","journal-title":"Mol Neurodegener"},{"key":"6218_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","volume":"17","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Abdel-Aziz AK, Abdelfatah S et al (2021) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy 17:1\u2013382. https:\/\/doi.org\/10.1080\/15548627.2020.1797280","journal-title":"Autophagy"},{"key":"6218_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25168971","volume":"25","author":"RP Guimar\u00e3es","year":"2024","unstructured":"Guimar\u00e3es RP, Resende M, Tavares MM et al (2024) Construct, face, and predictive validity of Parkinson\u2019s disease rodent models. Int J Mol Sci 25:8971. https:\/\/doi.org\/10.3390\/IJMS25168971","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6218_CR140","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","volume":"13","author":"M Faria","year":"2018","unstructured":"Faria M, Bj\u00f6rnmalm M, Thurecht KJ et al (2018) Minimum information reporting in bio\u2013nano experimental literature. Nat Nanotechnol 13(9):777\u2013785. https:\/\/doi.org\/10.1038\/s41565-018-0246-4","journal-title":"Nat Nanotechnol"},{"issue":"7419","key":"6218_CR141","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature11556","volume":"490","author":"SC Landis","year":"2012","unstructured":"Landis SC, Amara SG, Asadullah K et al (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490(7419):187\u2013191. https:\/\/doi.org\/10.1038\/nature11556","journal-title":"Nature"},{"key":"6218_CR142","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1021\/ACSCHEMNEURO.3C00070","volume":"14","author":"R Roy","year":"2023","unstructured":"Roy R, Paul R, Bhattacharya P, Borah A (2023) Combating dopaminergic neurodegeneration in Parkinson\u2019s disease through nanovesicle technology. ACS Chem Neurosci 14:2830\u20132848. https:\/\/doi.org\/10.1021\/ACSCHEMNEURO.3C00070","journal-title":"ACS Chem Neurosci"},{"key":"6218_CR143","doi-asserted-by":"publisher","unstructured":"Lababidi JM, Azzazy HMES (2025) Revamping Parkinson\u2019s disease therapy using PLGA-based drug delivery systems. npj Parkinson\u2019s Disease 2025 11:1 11:248-. https:\/\/doi.org\/10.1038\/s41531-025-01081-1","DOI":"10.1038\/s41531-025-01081-1"},{"issue":"2","key":"6218_CR144","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/S10311-023-01682-3","volume":"22","author":"AI Osman","year":"2024","unstructured":"Osman AI, Zhang Y, Farghali M et al (2024) Synthesis of green nanoparticles for energy, biomedical, environmental, agricultural, and food applications: a review. Environ Chem Lett 22(2):841\u2013887. https:\/\/doi.org\/10.1007\/S10311-023-01682-3","journal-title":"Environ Chem Lett"},{"key":"6218_CR145","doi-asserted-by":"publisher","first-page":"23684","DOI":"10.1021\/ACSNANO.4C08279","volume":"18","author":"G Wang","year":"2024","unstructured":"Wang G, Zhai Z, Wang W et al (2024) Tailored borneol-modified lipid nanoparticles nasal spray for enhanced nose-to-brain delivery to central nervous system diseases. ACS Nano 18:23684\u201323701. https:\/\/doi.org\/10.1021\/ACSNANO.4C08279","journal-title":"ACS Nano"},{"key":"6218_CR146","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1021\/ACSNANO.5C20622\/SUPPL_FILE\/NN5C20622_SI_003.MP4","volume":"20","author":"T Li","year":"2026","unstructured":"Li T, Xiao L, Chen Z et al (2026) Intranasal conformal patch for sustained levodopa delivery and reactive oxygen species scavenging in Parkinson\u2019s disease. ACS Nano 20:7817\u20137830. https:\/\/doi.org\/10.1021\/ACSNANO.5C20622\/SUPPL_FILE\/NN5C20622_SI_003.MP4","journal-title":"ACS Nano"},{"key":"6218_CR147","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1021\/ACS.MOLPHARMACEUT.4C00065","volume":"21","author":"MB McGuckin","year":"2024","unstructured":"McGuckin MB, Hutton ARJ, Davis ER et al (2024) Transdermal delivery of pramipexole using microneedle technology for the potential treatment of Parkinson\u2019s disease. Mol Pharm 21:2512\u20132533. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.4C00065","journal-title":"Mol Pharm"},{"key":"6218_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11020084","author":"MC Bonferoni","year":"2019","unstructured":"Bonferoni MC, Rossi S, Sandri G et al (2019) Nanoemulsions for \u201cnose-to-brain\u201d drug delivery. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics11020084","journal-title":"Pharmaceutics"},{"key":"6218_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020678","author":"MD Ferreira","year":"2023","unstructured":"Ferreira MD, Duarte J, Veiga F et al (2023) Nanosystems for brain targeting of antipsychotic drugs: an update on the most promising nanocarriers for increased bioavailability and therapeutic efficacy. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15020678","journal-title":"Pharmaceutics"},{"key":"6218_CR150","doi-asserted-by":"publisher","first-page":"15769","DOI":"10.2147\/IJN.S572417","volume":"20","author":"M Zheng","year":"2025","unstructured":"Zheng M, Hong X, Liao P et al (2025) Plant-derived exosome-like nanoparticles: a promising therapeutic for neurological disorders and drug delivery. Int J Nanomedicine 20:15769. https:\/\/doi.org\/10.2147\/IJN.S572417","journal-title":"Int J Nanomedicine"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06218-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:58:12Z","timestamp":1790002692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06218-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6218"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06218-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None to declare.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed and approved the final version of this manuscript for submission, confirming that it is accurate and that they are accountable for all aspects of the work.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to disclose.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We assert that this manuscript is original, has not been published previously and is not under consideration elsewhere.","order":4,"name":"Ethics","label":"Originality and Exclusivity","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, BioRender was employed for figure preparation and Grammarly was used for grammatical and language editing respectively. The authors reviewed and edited and approved the final content and take full responsibility for the accuracy and integrity of the manuscript.","order":6,"name":"Ethics","label":"Declaration of Generative AI and AI-Assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"914"}}